Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker
Hye Youn Sung(Ewha Womans University), Seung‐Ki Kim(Seoul National University Children's Hospital)
Cited by 19
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|369
Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer
|Experimental & Molecular Medicine|2017|61